Print Page  Close Window


SEC Filings

S-1/A
OREXIGEN THERAPEUTICS, INC. filed this Form S-1/A on 04/09/2007
Entire Document
 
 

OREXIGEN THERAPEUTICS, INC.
2004 STOCK PLAN
NOTICE OF STOCK OPTION GRANT
«Optionee»:
     You have been granted an option to purchase Common Stock of Orexigen Therapeutics, Inc. (the “Company”) as follows:
     
Date of Grant:
  «GrantDate»
 
   
Exercise Price per Share:
  «ExercisePrice»
 
   
Total Number of Shares Granted:
  «NoofShares»
 
   
Total Exercise Price:
  «TotalExercisePrice»
 
   
Type of Option:
  «ISO»«NSO»
 
   
Expiration Date:
  «ExpirDate10_years_from_grant»
 
   
Vesting Commencement Date:
  «VestingCommencementDate»
 
   
Vesting Schedule:
  So long as your Continuous Service Status with the Company continues, the Shares underlying this Option shall vest and become exerciseable in accordance with the following schedule: twenty-five percent (25%) of the total number of Shares subject to the Option shall vest on the 1st anniversary of the Vesting Commencement Date and 1/36th of the total remaining number of Shares subject to the Option shall vest on the same day of each month thereafter.
 
   
Termination Period:
  This Option may be exercised for ninety (90) days after termination of Optionee’s Continuous Service Status except as set out in Section 5 of the Stock Option Agreement (but in no event later than the Expiration Date). Optionee is responsible for keeping track of these exercise periods following termination for any reason of his or her service relationship with the Company. The Company will not provide further notice of such periods.
 
   
Transferability:
  This Option may not be transferred.